This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharma/Biotech GTN Summit
November 18-20, 2024
W Philadelphia HotelPhiladelphia, PA
November 18-20, 2024
W Philadelphia Hotel,
Philadelphia, PA

DELIVER MORE EFFECTIVE FORECASTS, ENHANCED VISIBILITY, PROFITABILITY AND CONTROL THROUGH BEST PRACTICES FOR GROSS-TO-NET MANAGEMENT

The Leading Event for Model-Sharing on Strategic Forecasting, Estimates, Analytics and Reporting for Pharma and Biotech Companies

Discover Why the Pharma/Biotech GTN Summit Continues to be an Industry Staple for Gross-to-Net Management

Whether your organization is pre-commercial revenue or managing multiple products and large revenue streams, the longstanding Pharma/Biotech GTN Summit provides depth around gross-to-net methodologies, best practices for forecasting models and hands-on learning of various financial automation tools.

Noteworthy Program Highlights

►  Pre-Conference Workshop: Provisions and Implications of the Inflation Reduction Act, part of the 2023 GTN Training Course Series

►  Two Concurrent Pre-Summit Seminars:

◈  Revenue Analytics Collaborative — ‘RAC’ Group Meeting

◈  GTN Bootcamp — A Comprehensive and Strategic Roadmap for GTN Processes

►  Insightful Fireside Chats with Life Sciences Finance & Accounting Experts

►  Exclusive Keynotes, Panels, Benchmarking and Q&As with CFOs, Controllers and Corporate Leadership from Bio/Pharma Companies and Audit/Advisory Firms

►  Finance Leaders Roundtable: Pioneers and Innovators of GTN Management & Financial Success — Blueprint for Thriving

►  Tracked Programming Based on Company Size and Maturity, Tailored for Large Bio/Pharma Organizations and Small/Emerging Biotechs

Prominent Industry Speakers

Hear from 60+ industry experts and fresh perspectives alike, including those representing:

►  AbbVie
►  Blueprint Medicines
►  Accord Healthcare
►  Apellis
►  Lilly USA
►  Teva Pharmaceuticals
►  CSL Behring
►  Novartis
►  Insmed Incorporated
►  Lundbeck
►  Ironshore Pharmaceuticals
►  Lifestar Pharma LLC
►  Collegium Pharmaceutical, Inc.
►  IntegriChain
►  AstraZeneca
►  Mirati Therapeutics
►  Galderma
►  Lannett Company
►  Cormedix
►  Novo Nordisk
►  GSK
►  Atrium Health
►  Ferring Pharmaceuticals Inc
►  Karyopharm Therapeutics Inc.
►  Bristol Myers Squibb
►  RSM US LLP

Up-To-Date Content

This year's content-rich, hybrid event boasts impactful new features, as well as the tried-and-true sessions requested year after year, covering all the many complexities that shape gross-to-net management, including:

  • Regulation & Policy Developments
  • Technology & Innovation
  • Market Access & Pricing
  • Tailored Strategies for Branded and Generic Businesses
  • GTN Excellence & Optimization

GTN Experts Arm You With...

Strategies, Practical Models and Key Considerations for GTN Excellence Through High Impact Education on the Hottest Topics Impacting GTN:

Regulation and Policy

  • Navigating the evolving regulatory and financial landscape by exploring the IRA, AMP cap removal and other policy proposals
  • Top tips and pitfalls to avoid when ensuring regulatory financial compliance and planning
  • Mitigating the impact of the branded prescription drug fee
  • Developments surrounding Medicare and Medicaid

Technological Innovation

  • Addressing the company’s GTN needs - use of automation, cloud & software in supporting GTN
  • In-house vs. outsourced solutions
  • What impact will AI have on analytics and forecasting?
  • Harnessing technological innovation & tools for enhancing forecasting & analytical capabilities
  • Revenue analytics and forecasting standards — Overview of the variety of data, tools, methodologies and documentation

Market Access and Pricing

  • Responding to regulatory pressures, payer price sensitivity and broader macroeconomic conditions
  • Careful balancing act: ensuring affordable access for patients whilst protecting margins
  • Understanding and navigating the complex network of pharma companies, payers, PBMs, healthcare providers and patients
  • Contracting and managed markets
  • Payer developments
  • Rebates and chargebacks

Audience Feedback

93%

rated the event as “Very Good” or “Excellent” in 2020

90%

attend to stay up to date with new trends and innovations

100%

attendees found the event met their objectives to connect with existing suppliers and leaders

92%

consider attendance to the GTN Summit to be important to their job/role

Stay Connected and Join the Conversation...

Tweet Your Learnings, Include #GTN2022

Connect with Our LinkedIn Finance & Accounting Network

Follow Us on Facebook

Connect and Network with Key Decision-Makers at Pharma/Biotech GTN Summit

Whether you’re looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.

For more information about custom opportunities to reach a qualified audience, please contact us.

Manager, Chargebacks

Fresenius Kabi

The GTN Summit offers a broad range of experiences and knowledge to help navigate this complex and unclear critical business area.

Put Yourself CenterStage

Build your personal brand. Position your company as leaders. Engage your community and peers.

Join CenterStage, Informa Connect's speaker rewards program, and get access to new opportunities to speak, create content, and get published on our online platforms. Earn points and redeem them for rewards every time you speak at an event or your content is viewed on Streamly - the new business video platform, powered by Informa, for experts, by experts like you. 

You'll have member access to resources, to guide you through the process and intricacies of showcasing your stories, expertise, learnings, and content across a wide range of in-person, hybrid, and virtual events.